Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study-Reference-Cited by-同舟云学术

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study

Published:2017-06-28 Issue:40 Volume:8 Page:67696-67708
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Navarria Pierina¹,Pessina Federico²,Tomatis Stefano¹,Soffietti Riccardo³,Grimaldi Marco⁴,Lopci Egesta⁵,Chiti Arturo⁵⁶,Leonetti Antonella⁷,Casarotti Alessandra²,Rossi Marco²,Cozzi Luca¹,Ascolese Anna Maria¹,Simonelli Matteo⁸⁶,Marcheselli Simona⁹,Santoro Armando⁸⁶,Clerici Elena¹,Bello Lorenzo²,Scorsetti Marta¹⁶

Affiliation:

1. Radiotherapy and Radiosurgery Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy

2. Neurosurgical Oncology Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy

3. Consultant of Neurosurgical Oncology Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy

4. Neuroradiology Unit, Radiology Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy

5. Nuclear Medicine Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy

6. Department of Biomedical Sciences, Humanitas University, Rozzano, Italy

7. Laboratory of Motor Control, Department of Medical Biotechnology and Translational Medicine, Milan University, Milan, Italy

8. Hematology and Oncology Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy

9. Department of Neurology, Humanitas Cancer Center and Research Hospital, Rozzano, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twenty Years of Advancements in a Radiotherapy Facility: Clinical Protocols, Technology, and Management;Current Oncology;2023-07-22

2. Evaluating the role of HYpofractionated RAdiotherapy schedule in High Grade GlioMA patients less than 60 years of age during the COVID period- A single Institutional Prospective Observational Study (HYRAMA study);2023-06-26

3. Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis;Journal of Neuro-Oncology;2021-12-23

4. In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy;International Journal of Molecular Sciences;2021-09-09

5. Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study;Journal of Clinical Medicine;2021-05-25